Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07115901 · ClinicalTrials.gov registry record · NA
Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release
A NA study of HIV (Human Immunodeficiency Virus), sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT07115901: Recruiting NA study of HIV (Human Immunodeficiency Virus), sponsored by University of California, San Francisco.
NCT07115901 is a NA study of HIV (Human Immunodeficiency Virus) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 33 participants, below the 77-participant average among 4 other HIV (Human Immunodeficiency Virus) trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07115901, a NA study of HIV (Human Immunodeficiency Virus), is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with HIV with criminal legal involvement (PWH-CLI). The main questions it aims to answer are: * How acceptable is a GI intervention, and its intervention components, among PWH-CLI participants and stakeholders? * How feasible is a GI intervention for PWH-CLI? What are the implementation barriers and opportunities for this intervention? * What is the preliminary efficacy of the GI intervention on improving HIV care outcomes for PWH-CLI? Researches will compare study engagement and study outcomes across three randomization arms (A: receive full GI amount as one lump sum payment; B: receive full GI amount split over nine monthly installments; C: participant chooses whether to receive GI as lump sum payment or monthly installments). HIV care outcomes will be compared against a retrospective cohort of PWH-CLI patients as historical controls. Participants will: * Be randomized to receive GI intervention as a lump sum payment or monthly installment (over nine months) or choose their preference. * Complete 3 surveys throughout study follow up to assess experience with the intervention, experience with social services and benefits programs, experience with the criminal legal system, and HIV care outcomes. * Be interviewed by the research team to further understand the experience with the intervention.
Primary Outcome
Percent of participants (total and by randomization arm) that are HIV virally suppressed at 9 months
Conditions Studied
Interventions
- OTHER Lump sum
- OTHER Monthly installments
- OTHER Choice
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2027-02-25 |
| Phase | NA |
What NCT07115901 shows while recruiting
NCT07115901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 77-participant average among 4 other HIV (Human Immunodeficiency Virus) trials with a reported enrollment target (57% lower).
The record links to 1 condition, with HIV (Human Immunodeficiency Virus) appearing as the primary indexed condition, and to 3 interventions - of which Lump sum is the first listed.
NCT07115901 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07115901 about?
NCT07115901 is a clinical study titled "Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release". The goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with HIV with criminal legal involvement (PWH-CLI). The main questions it aims to answer are: * How acceptable is a GI inter...
What is the current status of trial NCT07115901?
This trial is currently recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2025-12-01. Estimated completion is 2027-02-25.
What conditions does trial NCT07115901 study?
This clinical trial studies the following conditions: HIV (Human Immunodeficiency Virus).
What interventions are being tested in trial NCT07115901?
The interventions under investigation include: Lump sum (OTHER), Monthly installments (OTHER), Choice (OTHER).
Who is sponsoring clinical trial NCT07115901?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07115901 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV (Human Immunodeficiency Virus)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI